Dr. Colleen Strain sits down with John Sproule, from the Institute of Health Economics, to tackle the topic of health economics in a rapid-fire dialogue and exchange.
Manager, Scientific Leadership and Education, Core Diagnostics
Colleen Strain, PhD is a Scientific Manager for Global Scientific Leadership and Education at Abbott. She is also on the scientific lead for the UNIVANTS of Healthcare Excellence program and lead for the Executive Leadership Exchange program. As a champion for laboratory medicine, Colleen is passionate about driving healthcare excellence through scientific collaborations and partnerships, while maximizing value within healthcare.
Colleen’s professional and education focus on the strategic value of laboratory medicine within healthcare. Colleen is a corporate representative on the International Federations of Clinical Chemistry (IFCC)– Task Force on Outcome Studies in Laboratory Medicine and actively supports the IFCC Task Force for Corporate Members.
Colleen Strain reported the following relevant financial disclosures:
• Salary: Abbott
• Stocks/Bonds: Abbott
Senior Policy Director
Institution of Health Economics, Canada
John Sproule is the Institute of Health Economics’ Senior Policy Director. His main background has been working in the public sector in Canada, working in senior positions in government, government agencies and health authorities involved in managing health systems. He also has worked for the private health industry sector both in Canada and Australia. He currently sits on the Advisory Committee for the North American Observatory on Health Systems and Policies and has been a Board member with the Canadian Health Economics Research Association, the Canadian Association for Population Therapeutics, the Canadian Association for Health Services and Policy Research, Health Technology Assessment International, and Chair of the US/Canada Pacific Northwest Economic Region Health Care Working Group. In 2022 John received the Queen Elizabeth II Platinum Jubilee Medal for his contributions to ongoing innovation in the Canadian and Alberta health system.
John Sproule reported no relevant financial disclosures.